Skip to main content
. 2021 Jul 14;12:713592. doi: 10.3389/fendo.2021.713592

Table 1.

Key characteristics of patients in each cohort.

Cohort-0 Cohort-1A Cohort-1B Cohort-2 Cohort-3 Cohort-4
N 1057 632 250 130 137 289
Man/Woman (woman %) 223/834 (78.9%) 296/336 (53.2%) 104/146 (58.4%) 60/70 (53.8%) 50/87 (63.5%) 81/208 (72.0%)
Age (years) 30 (25, 36) 28 (21, 34) 31 (24, 36) 30 (23, 36) 29 (23, 35) 30 (25, 36)
BMI (kg/m2) 21.2 (19.9, 22.5) 33.6 (30.2, 37.5) 39.3 (35.7, 43.8) 38.7 (34.6, 43.1) 38.0 (34.5, 42.5) 36.8 (31.9, 42.5)
Systolic pressure (mmHg) 112 (106, 121) 133 (122, 145) 134 (125, 149) 137 (128, 150) 128 (124, 138) NA
Diastolic pressure (mmHg) 70 (64, 77) 86 (78, 93) 81 (74, 90) 88 (79, 98) 83 (75, 96) NA
HbA1c (%) 5.3 (5.0, 6.0) 5.7 (5.4, 6.3) 6.0 (5.6, 6.8) 5.8 (5.4, 6.4) 5.7 (5.4, 6.3) 5.8 (5.4, 6.3)
Fasting glucose (mmol/l) 4.6 (4.3, 5.0) 5.2 (4.8, 5.8) 5.5 (5.0, 6.8) 5.1 (4.7, 6.0) 5.4 (4.9, 6.4) 5.4 (5.0, 6.2)
OGTT 2hr glucose (mmol/l) 6.2 (5.1, 7.6) 7.4 (6.1, 9.4) 8.9 (6.7, 12.3) 8.0 (6.6, 10.1) 7.2 (5.9, 10.0) NA
Fasting insulin (mU/l) 9.13 (5.68, 13.57) 25.45 (17.08, 35.48) 28.19 (19.42, 42.63) 26.66 (19.22, 38.49) 33.09 (20.85, 49.21) 27.87 (18.74, 42.24)
OGTT 2hr insulin (mU/l) 64.30 (39.98, 101.90) 125.95 (71.02, 217.00) 137.10 (66.10, 233.90) 139.30 (80.61, 221.50) 112.10 (68.28, 192.20) NA
Total cholesterol (mmol/l) 4.22 (3.76, 4.67) 4.78 (4.14, 5.44) 4.53 (3.92, 5.19) 4.52 (3.96, 5.27) 5.08 (4.31, 5.59) NA
Triglyceride (mmol/l) 0.74 (0.60, 1.01) 1.61 (1.15, 2.25) 1.53 (1.17, 2.15) 1.71 (1.15, 2.17) 1.76 (1.29, 2.57) NA
Uric acid (μmol/l) 267 (236, 303) 412 (341, 481) 412 (359, 481) 464 (373, 533) 439 (377, 518) 391 (318, 454)
Creatinine (μmol/L) 56.0 (50.0, 62.0) 68.1 (57.0, 77.8) 59.4 (53.4, 68.7) 55.5 (47.0, 66.0) 60.9 (49.0, 68.3) NA
ALT (U/L) 13 (10, 16) 43 (24, 75) 42 (25, 77) 46 (28, 80) 47 (24, 81) NA
AST (U/L) 18 (15, 22) 28 (20, 43) 27 (18, 43) 30 (20, 46) 29 (20, 53) NA

Values are shown as median (IQR 25-75%). ALT, alanine aminotransferase; AST, aspartate aminotransferase; BMI, body mass index; HbA1c, glycosylated hemoglobin a1c; NA, not available; OGTT, oral glucose tolerance test.